To our knowledge, significant associations between BAFF/APRIL and plasma lipids have only been reported in small sample of patients with membranous nephropathy [21], children with ANCA-associated glomerulonephritis (GN) [22] and in patients with obesity [23]. Here, TNFSF13 is linked to membranous glomerulonephritis.